Predictive factors for subsequent intrahepatic cholangiocarcinoma associated with hepatolithiasis: Japanese National Cohort Study for 18 years

被引:13
|
作者
Suzuki, Yutaka [1 ]
Mori, Toshiyuki [1 ]
Momose, Hirokazu [1 ]
Matsuki, Ryota [1 ]
Kogure, Masaharu [1 ]
Abe, Nobutsugu [1 ]
Isayama, Hiroyuki [2 ]
Tazuma, Susumu [3 ]
Tanaka, Atsushi [4 ]
Takikawa, Hajime [5 ]
Sakamoto, Yoshihiro [1 ]
机构
[1] Kyorin Univ, Dept Gastrointestinal & Gen Surg, Sch Med, 6-20-2 Shinkawa, Mitaka, Tokyo 1818611, Japan
[2] Juntendo Univ, Grad Sch Med, Dept Gastroenterol, Tokyo, Japan
[3] JA Onomichi Gen Hosp, Hiroshima, Japan
[4] Teikyo Univ, Dept Med, Sch Med, Tokyo, Japan
[5] Teikyo Univ, Fac Med Technol, Tokyo, Japan
关键词
Intrahepatic cholangiocarcinoma associated with hepatolithiasis; Residual stones; Biliary strictures; Management of hepatolithiasis; RISK-FACTORS; HEPATECTOMY; RESECTION; OUTCOMES;
D O I
10.1007/s00535-022-01868-6
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Background Predictive factors for intrahepatic cholangiocarcinoma in long-term follow-up of hepatolithiasis are unknown. We thus conducted a cohort study to investigate the predictive factors for developing intrahepatic cholangiocarcinoma in hepatolithiasis. Methods This cohort is comprised of 401 patients registered in a nationwide survey of hepatolithiasis for 18 years of follow-up. Cox regression analysis was used to elucidate predictive factors for developing intrahepatic cholangiocarcinoma. Results The median follow-up period of patients was 134 months. Twenty-two patients developed intrahepatic cholangiocarcinoma and all died. Identified independent significant factors were as follows: age 63 years or older (hazard ratio [HR] 3.344), residual stones at the end of treatment (HR 2.445), and biliary stricture during follow-up (HR 4.350). The incidence of intrahepatic cholangiocarcinoma in patients with three factors was significantly higher than that in patients with one or two factors. The incidence in the groups with one or two predictive factors was not different. In 88.9% of patients with both biliary stricture and intrahepatic cholangiocarcinoma, the duration between the diagnoses of biliary stricture and intrahepatic cholangiocarcinoma was >= 5 years. However, once intrahepatic cholangiocarcinoma developed, 77.8% of patients died within 1 year. Of 24 patients with no symptoms, no previous choledocoenterostomy, no signs of malignancy, no biliary stricture, and no treatment for hepatolithiasis during follow-up, only one developed intrahepatic cholangiocarcinoma. Conclusions Regarding carcinogenesis, complete stone clearance and releasing biliary stricture can prevent the development of intrahepatic cholangiocarcinoma and improve the prognosis of hepatolithiasis.
引用
收藏
页码:387 / 395
页数:9
相关论文
共 50 条
  • [1] Predictive factors for subsequent intrahepatic cholangiocarcinoma associated with hepatolithiasis: Japanese National Cohort Study for 18 years
    Yutaka Suzuki
    Toshiyuki Mori
    Hirokazu Momose
    Ryota Matsuki
    Masaharu Kogure
    Nobutsugu Abe
    Hiroyuki Isayama
    Susumu Tazuma
    Atsushi Tanaka
    Hajime Takikawa
    Yoshihiro Sakamoto
    Journal of Gastroenterology, 2022, 57 : 387 - 395
  • [2] Risk factors of intrahepatic cholangiocarcinoma in patients with hepatolithiasis: a case-control study
    Liu, Zhen-Yu
    Zhou, Yan-Ming
    Shi, Le-Hua
    Yin, Zheng-Feng
    HEPATOBILIARY & PANCREATIC DISEASES INTERNATIONAL, 2011, 10 (06) : 626 - 631
  • [3] Risk factors of intrahepatic cholangiocarcinoma in patients with hepatolithiasis:a case-control study
    Zhen-Yu Liu
    Department of Hepato-Biliary-Pancreato-Vascular Surgery
    Hepatobiliary&PancreaticDiseasesInternational, 2011, 10 (06) : 626 - 631
  • [4] Role of surgical treatment for hepatolithiasis-associated intrahepatic cholangiocarcinoma: A retrospective study in a single institution
    Xiao, Jian
    Zhu, Jisheng
    Liu, Zhanying
    Wan, Renhua
    Li, Yong
    Xiao, Weidong
    JOURNAL OF CANCER RESEARCH AND THERAPEUTICS, 2017, 13 (05) : 756 - 760
  • [5] Sarcopenia as a prognostic factor in hepatolithiasis-associated intrahepatic cholangiocarcinoma patients following hepatectomy: a retrospective study
    Zhou, Gongting
    Bao, Haili
    Zeng, Qiqiang
    Hu, Weijian
    Zhang, Qiyu
    INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL MEDICINE, 2015, 8 (10): : 18245 - 18254
  • [6] Prognostic Risk Factors Associated with Recurrence and Metastasis After Radical Resection in Patients with Hepatolithiasis Complicated by Intrahepatic Cholangiocarcinoma
    Zhu, Yufei
    Zhu, Yunhai
    Cai, Feng
    Zhao, Jie
    Liu, Feng
    CELL BIOCHEMISTRY AND BIOPHYSICS, 2015, 73 (02) : 455 - 460
  • [7] Identification of prognostic factors and the impact of palliative resection on survival of patients with stage IV hepatolithiasis-associated intrahepatic cholangiocarcinoma
    Zhang, Guo-Wei
    Lin, Jian-Hua
    Qian, Jian-Ping
    Zhou, Jie
    JOURNAL OF SURGICAL ONCOLOGY, 2014, 109 (05) : 494 - 499
  • [8] Prognostic factors in patients with recurrent intrahepatic cholangiocarcinoma after curative resection: A retrospective cohort study
    Ohira, Masahiro
    Kobayashi, Tsuyoshi
    Hashimoto, Masakazu
    Tazawa, Hirofumi
    Abe, Tomoyuki
    Oshita, Akihiko
    Kohashi, Toshihiko
    Irei, Toshimitsu
    Oishi, Koichi
    Ohdan, Hideki
    INTERNATIONAL JOURNAL OF SURGERY, 2018, 54 : 156 - 162
  • [9] Neoadjuvant Chemotherapy for Intrahepatic, Perihilar, and Distal Cholangiocarcinoma: a National Population-Based Comparative Cohort Study
    Parente, Alessandro
    Kamarajah, Sivesh K.
    Baia, Marco
    Tirotta, Fabio
    Manzia, Tommaso M.
    Hilal, Mohammed Abu
    Pawlik, Timothy M.
    White, Steven A.
    Dahdaleh, Fadi S.
    JOURNAL OF GASTROINTESTINAL SURGERY, 2023, 27 (04) : 741 - 749
  • [10] Neoadjuvant Chemotherapy for Intrahepatic, Perihilar, and Distal Cholangiocarcinoma: a National Population-Based Comparative Cohort Study
    Alessandro Parente
    Sivesh K. Kamarajah
    Marco Baia
    Fabio Tirotta
    Tommaso M. Manzia
    Mohammed Abu Hilal
    Timothy M. Pawlik
    Steven A. White
    Fadi S. Dahdaleh
    Journal of Gastrointestinal Surgery, 2023, 27 : 741 - 749